Julia Pohl1, Ulrike B Hendgen-Cotta2, Pia Stock2, Peter Luedike2, Tienush Rassaf2. 1. University Hospital Essen, West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, Hufelandstr. 55, 45147 Essen, Germany. Electronic address: J.Pohl@uk-essen.de. 2. University Hospital Essen, West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, Hufelandstr. 55, 45147 Essen, Germany.
Abstract
PURPOSE: D-dopachrome tautomerase (MIF-2 or DDT) is a member of the macrophage migration inhibitory factor (MIF) superfamily and a close structural homolog to MIF. Circulating MIF-2 has been described to be elevated in patients suffering from sepsis, severe burn injury and after surgery. We sought to evaluate the prognostic value of MIF-2 in critically ill patients. METHODS: A total of 72 patients were studied upon admission to the medical intensive care unit (ICU). MIF and MIF-2 levels were assessed and compared to healthy controls. Clinical data, various laboratory parameters and mortality were assessed. RESULTS: We found significantly elevated levels of MIF-2 and MIF at admission to the ICU in critically ill patients compared to healthy controls. MIF-2 levels were associated with disease severity as measured by APACHE II scores. MIF-2 levels in ICU patients correlated with biomarkers reflecting organ damage, but were not influenced by acute or chronic kidney disease. Kaplan-Meier analysis revealed distinctly elevated mortality in patients with high plasma MIF-2 levels. CONCLUSIONS: MIF-2 levels are elevated in critically ill patients and linked to parameters of organ damage, supporting its value as a potential tool for the assessment of prognosis in critical illness.
PURPOSE:D-dopachrome tautomerase (MIF-2 or DDT) is a member of the macrophage migration inhibitory factor (MIF) superfamily and a close structural homolog to MIF. Circulating MIF-2 has been described to be elevated in patients suffering from sepsis, severe burn injury and after surgery. We sought to evaluate the prognostic value of MIF-2 in critically illpatients. METHODS: A total of 72 patients were studied upon admission to the medical intensive care unit (ICU). MIF and MIF-2 levels were assessed and compared to healthy controls. Clinical data, various laboratory parameters and mortality were assessed. RESULTS: We found significantly elevated levels of MIF-2 and MIF at admission to the ICU in critically illpatients compared to healthy controls. MIF-2 levels were associated with disease severity as measured by APACHE II scores. MIF-2 levels in ICU patients correlated with biomarkers reflecting organ damage, but were not influenced by acute or chronic kidney disease. Kaplan-Meier analysis revealed distinctly elevated mortality in patients with high plasma MIF-2 levels. CONCLUSIONS:MIF-2 levels are elevated in critically illpatients and linked to parameters of organ damage, supporting its value as a potential tool for the assessment of prognosis in critical illness.
Authors: Li-Rong Yu; Zhijun Cao; Issam Makhoul; Jaclyn R Daniels; Suzanne Klimberg; Jeanne Y Wei; Jane Pf Bai; Jinong Li; Julia T Lathrop; Richard D Beger; Valentina K Todorova Journal: Exp Biol Med (Maywood) Date: 2017-12-09
Authors: Alexander Gombert; Christian Stoppe; Ann Christina Foldenauer; Tobias Schuerholz; Lukas Martin; Johannes Kalder; Gereon Schälte; Gernot Marx; Michael Jacobs; Jochen Grommes Journal: Int J Mol Sci Date: 2017-11-09 Impact factor: 5.923
Authors: Christian Bime; Sara M Camp; Nancy Casanova; Radu C Oita; Juliet Ndukum; Heather Lynn; Joe G N Garcia Journal: Transl Res Date: 2020-06-26 Impact factor: 7.012